119 related articles for article (PubMed ID: 10084694)
1. The development of a bi-specific anti-CD161A x anti-tumor antibody for rat NK cell targeting.
Hagenaars M; Ensink NG; Jonges LE; Chambers WH; Eggermont AM; van de Velde CJ; Fleuren GJ; Kuppen PJ
Immunobiology; 1999 Feb; 200(1):31-48. PubMed ID: 10084694
[TBL] [Abstract][Full Text] [Related]
2. The development and purification of a bispecific antibody for lymphokine-activated killer cell targeting against the rat colon carcinoma CC531.
Kuppen PJ; Eggermont AM; Smits KM; van Eendenburg JD; Lazeroms SP; van de Velde CJ; Fleuren GJ
Cancer Immunol Immunother; 1993 Jun; 36(6):403-8. PubMed ID: 8500112
[TBL] [Abstract][Full Text] [Related]
3. Bispecific monoclonal antibodies directed to CD16 and to a tumor-associated antigen induce target-cell lysis by resting NK cells and by a subset of NK clones.
Ferrini S; Prigione I; Miotti S; Ciccone E; Cantoni C; Chen Q; Colnaghi MI; Moretta L
Int J Cancer; 1991 May; 48(2):227-33. PubMed ID: 1826900
[TBL] [Abstract][Full Text] [Related]
4. Administration of BiMAb-retargeted T cells in a rat hepatic metastases colon tumour model results in T-cell tumour infiltration independent of the route of administration.
Koelemij R; Hagenaars M; Ensink NG; Eggermont AM; Van De Velde CJ; Fleuren GJ; Kuppen PJ
Scand J Immunol; 2001 Mar; 53(3):277-81. PubMed ID: 11251885
[TBL] [Abstract][Full Text] [Related]
5. Use of anti-CD3 and anti-CD16 bispecific monoclonal antibodies for the targeting of T and NK cells against tumor cells.
Ferrini S; Cambiaggi A; Sforzini S; Canevari S; Mezzanzanica D; Colnaghi MI; Moretta L
Cancer Detect Prev; 1993; 17(2):295-300. PubMed ID: 8402715
[TBL] [Abstract][Full Text] [Related]
6. Characterization of four new monoclonal antibodies that recognize mouse natural killer activation receptors.
Kung SK; Su RC; Shannon J; Miller RG
Hybridoma; 2001 Apr; 20(2):91-101. PubMed ID: 11394535
[TBL] [Abstract][Full Text] [Related]
7. High expression of NKR-P1 is not an absolute requirement for natural killer activity in BDIX rats.
Pinard D; Olsson NO; Chambers WH; Martin F
Cancer Immunol Immunother; 1996 Jan; 42(1):15-23. PubMed ID: 8625362
[TBL] [Abstract][Full Text] [Related]
8. NKR-P1A stimulation of arachidonate-generating enzymes in rat NK cells is associated with granule release and cytotoxic activity.
Grazia Cifone M; Roncaioli P; Cironi L; Festuccia C; Meccia A; D'Aló S; Botti D; Santoni A
J Immunol; 1997 Jul; 159(1):309-17. PubMed ID: 9200468
[TBL] [Abstract][Full Text] [Related]
9. Co-Stimulatory Bispecific Antibodies Induce Enhanced T Cell Activation and Tumor Cell Killing in Breast Cancer Models.
Warwas KM; Meyer M; Gonçalves M; Moldenhauer G; Bulbuc N; Knabe S; Luckner-Minden C; Ziegelmeier C; Heussel CP; Zörnig I; Jäger D; Momburg F
Front Immunol; 2021; 12():719116. PubMed ID: 34484225
[TBL] [Abstract][Full Text] [Related]
10. NKR-P1A is a target-specific receptor that activates natural killer cell cytotoxicity.
Ryan JC; Niemi EC; Nakamura MC; Seaman WE
J Exp Med; 1995 May; 181(5):1911-5. PubMed ID: 7722466
[TBL] [Abstract][Full Text] [Related]
11. A CD16/CD30 bispecific monoclonal antibody induces lysis of Hodgkin's cells by unstimulated natural killer cells in vitro and in vivo.
Hombach A; Jung W; Pohl C; Renner C; Sahin U; Schmits R; Wolf J; Kapp U; Diehl V; Pfreundschuh M
Int J Cancer; 1993 Nov; 55(5):830-6. PubMed ID: 8244580
[TBL] [Abstract][Full Text] [Related]
12. Initiation and development of experimental autoimmune neuritis in Lewis rats is independent of the cytotoxic capacity of NKR-P1A+ cells.
Yu S; Zhu Y; Chen Z; Alheim M; Ljungberg A; Zhu J
J Neurosci Res; 2002 Mar; 67(6):823-8. PubMed ID: 11891797
[TBL] [Abstract][Full Text] [Related]
13. Functional heterogeneity between NKR-P1bright/Lycopersicon esculentum lectin (L.E.)bright and NKR-P1bright/L.E.dim subpopulations of rat natural killer cells.
Chambers WH; Brumfield AM; Hanley-Yanez K; Lakomy R; Herberman RB; McCaslin DC; Olszowy MW; McCoy JP
J Immunol; 1992 Jun; 148(11):3658-65. PubMed ID: 1588052
[TBL] [Abstract][Full Text] [Related]
14. Human NKR-P1A. A disulfide-linked homodimer of the C-type lectin superfamily expressed by a subset of NK and T lymphocytes.
Lanier LL; Chang C; Phillips JH
J Immunol; 1994 Sep; 153(6):2417-28. PubMed ID: 8077657
[TBL] [Abstract][Full Text] [Related]
15. A Role of NKR-P1A (CD161) and Lectin-like Transcript 1 in Natural Cytotoxicity against Human Articular Chondrocytes.
Białoszewska A; Olkowska-Truchanowicz J; Bocian K; Osiecka-Iwan A; Czop A; Kieda C; Malejczyk J
J Immunol; 2018 Jan; 200(2):715-724. PubMed ID: 29212911
[TBL] [Abstract][Full Text] [Related]
16. The LFA-1/ICAM cell adhesion pathway is involved in tumor-cell lysis mediated by bispecific monoclonal-antibody-targeted T lymphocytes.
Ferrini S; Sforzini S; Cambiaggi A; Poggi A; Meazza R; Canevari S; Colnaghi MI; Moretta L
Int J Cancer; 1994 Mar; 56(6):846-52. PubMed ID: 7907079
[TBL] [Abstract][Full Text] [Related]
17. Targeting of T or NK lymphocytes against tumor cells by bispecific monoclonal antibodies: role of different triggering molecules.
Ferrini S; Cambiaggi A; Cantoni C; Canevari S; Mezzanzanica D; Colnaghi MI; Moretta L
Int J Cancer Suppl; 1992; 7():15-8. PubMed ID: 1428398
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-12 increases bispecific-antibody-mediated natural killer cell cytotoxicity against human tumors.
Sahin U; Kraft-Bauer S; Ohnesorge S; Pfreundschuh M; Renner C
Cancer Immunol Immunother; 1996 Jan; 42(1):9-14. PubMed ID: 8625370
[TBL] [Abstract][Full Text] [Related]
19. Targeting of saporin to Hodgkin's lymphoma cells by anti-CD30 and anti-CD25 bispecific antibodies.
Sforzini S; de Totero D; Gaggero A; Ippoliti R; Glennie MJ; Canevari S; Stein H; Ferrini S
Br J Haematol; 1998 Sep; 102(4):1061-8. PubMed ID: 9734659
[TBL] [Abstract][Full Text] [Related]
20. Expression cloning and function of the rat NK activating and inhibitory receptors NKR-P1A and -P1B.
Li J; Rabinovich BA; Hurren R; Shannon J; Miller RG
Int Immunol; 2003 Mar; 15(3):411-6. PubMed ID: 12618485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
